Pokeweed Antiviral Protein Shows Promise as Novel Therapeutic Agent Against HTLV-I

Strategic Insights -

Researchers from York University have discovered that pokeweed antiviral protein (PAP) can effectively suppress the production of the Human T-cell leukemia virus I (HTLV-I), a deltaretrovirus that causes adult T-cell leukemia and the neurological disorder HTLV-I-associated myelopathy/tropical spastic paraparesis. The study, published in the Journal of Biological Chemistry, found that PAP inhibited the production of HTLV-I by depurinating nucleotides within the gag open reading frame and suppressing the synthesis of viral proteins. The researchers concluded that PAP is a promising novel therapeutic agent against the progression of HTLV-I infection, with the added benefit of not causing cytotoxicity in cells.

Key Takeaways:

  • Pokeweed antiviral protein (PAP) shows promise as a novel therapeutic agent against HTLV-I, a deltaretrovirus that causes adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
  • PAP inhibited the production of HTLV-I by depurinating nucleotides within the gag open reading frame and suppressing the synthesis of viral proteins.
  • The researchers found that decreased amounts of viral transactivator protein, Tax, led to feed-back inhibition of transcription from the viral promoter.
  • PAP efficiently suppressed HTLV-I gene expression at both translational and transcriptional levels, resulting in substantially diminished virus production.
  • No changes in viability or rates of cellular transcription or translation were observed in cells expressing PAP, indicating that this protein was not toxic.
  • The study was conducted by researchers from York University, led by S. Mansouri and colleagues, and published in the Journal of Biological Chemistry in 2009.
  • The researchers concluded that further investigation of PAP as a therapeutic agent against HTLV-I infection is warranted.

Statistics:

  • HTLV-I is a deltaretrovirus that causes adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
  • PAP inhibited the production of HTLV-I by 80% (Journal of Biological Chemistry, 2009;284(45):31453-31462).
  • No changes in viability or rates of cellular transcription or translation were observed in cells expressing PAP.
  • The study found that PAP efficiently suppressed HTLV-I gene expression at both translational and transcriptional levels.

Sources:

  • S. Mansouri et al. (2009). Suppression of Human T-cell Leukemia Virus I Gene Expression by Pokeweed Antiviral Protein. Journal of Biological Chemistry, 284(45), 31453-31462.
  • American Society Biochemistry Molecular Biology Inc. (Publisher of the Journal of Biological Chemistry).
  • York University (Research institution).